EX-23 12 ex232.txt EXHIBIT 23.2 - E&Y CONSENT Exhibit 23.2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS We consent to the reference to our firm under the caption "Experts" in this Registration Statement (Form S-3) and related Prospectus of Ligand Pharmaceuticals and to the incorporation by reference therein of our report dated February 22, 2000, with respect to the consolidated financial statements and schedules of Ligand Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 1999, filed with the Securities and Exchange Commission. /S/ERNST & YOUNG LLP San Diego, California January 10, 2003